The bacterial epigenome

MA Sánchez-Romero, J Casadesús - Nature Reviews Microbiology, 2020 - nature.com
In all domains of life, genomes contain epigenetic information superimposed over the
nucleotide sequence. Epigenetic signals control DNA–protein interactions and can cause …

Targeting DNA methylation with small molecules: what's next? Miniperspective

A Erdmann, L Halby, J Fahy… - Journal of medicinal …, 2015 - ACS Publications
DNA methylation is a mammalian epigenetic mark that is involved in defining where and
when genes are expressed, both in normal cells and in the context of diseases. Like other …

DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies

D Pechalrieu, C Etievant, PB Arimondo - Biochemical pharmacology, 2017 - Elsevier
DNA methylation is a mammalian epigenetic mark that participates to define where and
when genes are expressed, both in normal cells and in the context of diseases. Like other …

DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs

J Yu, T Xie, Z Wang, X Wang, S Zeng, Y Kang… - Drug Discovery …, 2019 - Elsevier
Highlights•The structure-related regulatory mechanisms of active DNMTs are outlined.•The
therapeutic importance of DNMTs in different cancer types is briefly compared.•The most …

Zebrafish as a model to study the role of DNA methylation in environmental toxicology

JH Kamstra, P Aleström, JM Kooter, J Legler - Environmental Science and …, 2015 - Springer
Environmental epigenetics is a rapidly growing field which studies the effects of
environmental factors such as nutrition, stress, and exposure to compounds on epigenetic …

Epigenetic modulators as therapeutic targets in prostate cancer

I Graça, E Pereira-Silva, R Henrique, G Packham… - Clinical …, 2016 - Springer
Prostate cancer is one of the most common non-cutaneous malignancies among men
worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or …

DNA methyltransferase inhibitors: an updated patent review (2012-2015)

P Xu, G Hu, C Luo, Z Liang - Expert opinion on therapeutic patents, 2016 - Taylor & Francis
ABSTRACT Introduction: DNA methyltransferases (DNMTs), important enzymes involved in
epigenetic regulation of gene expression, represent promising targets in cancer therapy …

Toward drug repurposing in epigenetics: olsalazine as a hypomethylating compound active in a cellular context

O Méndez‐Lucio, J Tran, JL Medina‐Franco… - …, 2014 - Wiley Online Library
DNA hypomethylating drugs that act on DNA methyltransferase (DNMT) isoforms are
promising anticancer agents. By using a well‐characterized live‐cell system to measure …

Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors

Z Yuan, Q Sun, D Li, S Miao, S Chen, L Song… - European Journal of …, 2017 - Elsevier
DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) are important
epigenetic targets during anticancer drug development. Recent study indicates that DNMT …

The DNMT3A R882H mutant displays altered flanking sequence preferences

M Emperle, A Rajavelu, S Kunert… - Nucleic acids …, 2018 - academic.oup.com
Abstract The DNMT3A R882H mutation is frequently observed in acute myeloid leukemia
(AML). It is located in the subunit and DNA binding interface of DNMT3A and has been …